StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright decreased their target price on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating […]
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report sent to investors on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reduced their target price on Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the […]
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reduced their price objective on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating for the company […]
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price target on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating on the […]
StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright dropped their target price on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating for the […]